Cherie A. Stayner
270 Great King Street
Dunedin, OTA 9054, New Zealand
Dunedin, OTA 9054, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
PAX gene expression in autosomal dominant polycystic kidney disease contributes to cyst expansion and regulates a gene network associated with cyst growth.
Journal: Human molecular genetics
Published: August 27, 2025
Building mission-led science communication and engagement capability in Aotearoa New Zealand: lessons from the National Science Challenges.
Journal: Journal of the Royal Society of New Zealand
Published: August 04, 2025
Authentic co-design: an essential prerequisite to health equity in Aotearoa New Zealand.
Journal: Journal of the Royal Society of New Zealand
Published: August 04, 2025
Non-coding RNAs as potential biomarkers and therapeutic targets in polycystic kidney disease.
Journal: Frontiers in physiology
Published: July 29, 2022
Recent Discoveries in Epigenetic Modifications of Polycystic Kidney Disease.
Journal: International journal of molecular sciences
Published: October 31, 2021
Extensive Inter-Cyst DNA Methylation Variation in Autosomal Dominant Polycystic Kidney Disease Revealed by Genome Scale Sequencing.
Journal: Frontiers in genetics
Published: January 09, 2020
Designing phantoms to accurately replicate circular depolarization in biological scattering media.
Journal: Applied optics
Published: December 25, 2019
Genome-Scale Single Nucleotide Resolution Analysis of DNA Methylation in Human Autosomal Dominant Polycystic Kidney Disease.
Journal: American journal of nephrology
Published: July 05, 2018
SMAD proteins directly suppress PAX2 transcription downstream of transforming growth factor-beta 1 (TGF-β1) signalling in renal cell carcinoma.
Journal: Oncotarget
Published: January 10, 2018
Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease.
Journal: Current medicinal chemistry
Published: November 02, 2017
Last Updated: 09/26/2026